Evidence map›Paper›PMID 30375456›Full record

ArticleScientific reports2018

Acid bone lysate activates TGFβ signalling in human oral fibroblasts.

Franz Josef Strauss, Alexandra Stähli, Lucian Beer, Goran Mitulović, Valentina Gilmozzi, Nina Haspel, Gerhild Schwab, Reinhard Gruber

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Acid bone lysates reduce bone regeneration in rat calvaria defects.Journal of biomedical materials research. Part A · 2021
    Article
  12. Article
  13. Article
  14. TGF-β Activity of a Demineralized Bone Matrix.International journal of molecular sciences · 2021
    Article
  15. Article
  16. Article
  17. Relative Centrifugal Force (RCF;International journal of molecular sciences · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Franz Josef StraussDepartment of Oral Biology, Medical University of Vienna, Sensengasse 2a, 1090, Vienna, Austria.ORCID http://orcid.org/0000-0002-5832-7327
Alexandra StähliDepartment of Oral Biology, Medical University of Vienna, Sensengasse 2a, 1090, Vienna, Austria.
Lucian BeerDepartment of Biomedical Imaging and Image-guided Therapy, Medical University Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Goran MitulovićClinical Department of Laboratory Medicine Proteomics Core Facility, Medical University Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.ORCID http://orcid.org/0000-0003-1964-3965
Valentina GilmozziDepartment of Oral Biology, Medical University of Vienna, Sensengasse 2a, 1090, Vienna, Austria.
Nina HaspelDepartment of Oral Biology, Medical University of Vienna, Sensengasse 2a, 1090, Vienna, Austria.
Gerhild SchwabDepartment of Oral Biology, Medical University of Vienna, Sensengasse 2a, 1090, Vienna, Austria.
Reinhard GruberDepartment of Oral Biology, Medical University of Vienna, Sensengasse 2a, 1090, Vienna, Austria. reinhard.gruber@meduniwien.ac.at.ORCID http://orcid.org/0000-0001-5400-9009

Funding

Osteology Foundation 14-126Osteology Foundation 17-125Osteology Foundation 17-219Osteology Foundation S-17-003
6 · The paper itself

Abstract

Demineralized bone matrix is a widely used allograft from which not only the inorganic mineral but also embedded growth factors are removed by hydrochloric acid (HCl). The cellular response to the growth factors released during the preparation of demineralized bone matrix, however, has not been studied. Here we investigated the in vitro impact of acid bone lysate (ABL) prepared from porcine cortical bone chips on oral fibroblasts. Proteomic analysis of ABL revealed a large spectrum of bone-derived proteins including TGF-β1. Whole genome microarrays and RT-PCR together with the pharmacologic blocking of TGF-β receptor type I kinase with SB431542 showed that ABL activates the TGF-β target genes interleukin 11, proteoglycan 4, and NADPH oxidase 4. Interleukin 11 expression was confirmed at the protein level by ELISA. Immunofluorescence and Western blot showed the nuclear localization of Smad2/3 and increased phosphorylation of Smad3 with ABL, respectively. This effect was independent of whether ABL was prepared from mandible, calvaria or tibia. These results demonstrate that TGF-β is a major growth factor that is removed upon the preparation of demineralized bone matrix.

Indexed as

ProteomicsAnimalsBenzamidesBone Demineralization TechniqueCortical BoneDentinDioxolesFibroblastsGene Expression Regulation, DevelopmentalGenomeHumansHydrochloric AcidInterleukin-11Microarray AnalysisMouth MucosaProteoglycans4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideBenzamidesDemineralized Dentin MatrixDioxolesHydrochloric AcidInterleukin-11ProteoglycansReceptor, Transforming Growth Factor-beta Type ISmad3 ProteinTransforming Growth Factor beta

Identifiers

PMID30375456
PMCPMC6207660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.